PeptidePedia The community reference

Special:RecentChanges

Change log·6,798 revisions·page 50 of 68

Every change to PeptidePedia Wiki, newest first. N marks a new page, m a minor edit and b an edit by an approved bot. The byte figure is the page size after the edit; the coloured figure is the change. 6,798 changes are logged in total.

6,798Logged changes
575Bot edits
167Page creations
256Active editors

23 January 2025

  1. (diff | hist) 17:42 Proglucagon 4,998 +742 ThymosinTamsin (talk | contribs) rm the sentence implying the hormone is a drug [rollback]
  2. (diff | hist) 17:15 Lyophilisation 16,876 +1,442 SurmountSurma (talk | contribs) correct the freezer temperature range given for long-term storage [rollback]
  3. (diff | hist) 15:16 Dose escalation schedule 3,510 +640 PrepHPLC_Pia (talk | contribs) state the assumption that the whole vial is reconstituted at once [rollback]
  4. (diff | hist) m 14:17 SURPASS trial programme 3,958 +184 SurmountSurma (talk | contribs) British spelling per PP:MOS [rollback]
  5. (diff | hist) 08:41 Talk:Bachem Holding (Suzhou) 959 +194 Chromatokid (talk | contribs) /* Purity without a reference standard */ reply
  6. (diff | hist) 05:03 Blind sampling 4,974 +153 BatchNumberBede (talk | contribs) add the second-opinion point: two services, one lot, is a stronger record [rollback]
  7. (diff | hist) m 03:49 Insulin syringe unit conversion 3,205 +119 BalanceBirdie (talk | contribs) expand §Scale comparison [rollback]
  8. (diff | hist) m b 00:58 Sarcopenia 2,738 +419 ArchiveBot (talk | contribs) bot: normalise citation format [rollback]

22 January 2025

  1. (diff | hist) 21:59 ChinaPeptides 6,153 +642 MelanocortinMil (talk | contribs) split overlong sentence [rollback]
  2. (diff | hist) m 17:48 Peptide stability table 1,939 +33 CrossRefCleve (talk | contribs) add the worked example that matches the default inputs [rollback]
  3. (diff | hist) 13:14 Talk:Bachem Holding (Suzhou) 748 +223 AnalyticalAnnie (talk | contribs) /* Purity without a reference standard */ reply
  4. (diff | hist) 09:36 Talk:Bachem Holding (Suzhou) 537 +245 AAA_Analyst (talk | contribs) /* Purity without a reference standard */ new section
  5. (diff | hist) 09:01 Active pharmaceutical ingredient 2,832 ±0 LabRangeLindy (talk | contribs) state that research-use-only labelling is a commercial category, not an approval [rollback]
  6. (diff | hist) m 08:45 Electrospray ionisation 3,226 +111 PeakShapePol (talk | contribs) add the reference standard and its traceability [rollback]
  7. (diff | hist) 08:30 Certificate of analysis 6,396 ±0 GlossaryGleb (talk | contribs) add the cost basis, since it shapes who submits [rollback]
  8. (diff | hist) m 00:47 Vial filling and stoppering 3,355 +582 StopperingSteff (talk | contribs) state that a phase-change pack and a gel pack behave differently [rollback]

21 January 2025

  1. (diff | hist) 17:12 Drug master file 2,228 ±0 SafetySignalSid (talk | contribs) add the pharmacopoeial chapter reference [rollback]
  2. (diff | hist) m 16:46 Crude peptide 3,318 ±0 SecretagogueSol (talk | contribs) correct the eutectic temperature — source gives a range [rollback]
  3. (diff | hist) 15:25 Semaglutide 7,098 +365 ComparisonCato (talk | contribs) add the structural figure and caption it properly [rollback]
  4. (diff | hist) 14:52 Deamidation 3,497 ±0 A1c_Alder (talk | contribs) correct the resolution formula — the denominator is the sum of the widths [rollback]
  5. (diff | hist) 09:35 Subcutaneous injection 4,039 +194 SelectTrialSam (talk | contribs) add the note that a smaller diluent volume raises concentration, not dose [rollback]
  6. (diff | hist) m 09:29 USP General Chapter 71 2,254 ±0 StyleSheetSybil (talk | contribs) correct the water-content figure — the source reports it on a dry basis [rollback]
  7. (diff | hist) 06:26 Tirzepatide 5,389 ±0 TimelineTiernan (talk | contribs) add CAS number, sourced [rollback]
  8. (diff | hist) m 05:32 Timeline of incretin therapeutics 3,151 +19 INN_Ingrid (talk | contribs) state plainly that the research-use-only form is not approved for human use [rollback]
  9. (diff | hist) 04:24 Peptide 4,059 ±0 AmylinAmos (talk | contribs) add short description [rollback]
  10. (diff | hist) 04:20 Solid-phase peptide synthesis 4,279 ±0 PrepHPLC_Pia (talk | contribs) add category for logistics [rollback]

20 January 2025

  1. (diff | hist) 20:58 Trial data comparison 2,049 +503 DiffWatchDov (talk | contribs) add the medical-disclaimer cross-link to the tool pages [rollback]
  2. (diff | hist) 17:13 Peptide supply chain 4,176 +33 Chromatokid (talk | contribs) correct the freezer temperature range given for long-term storage [rollback]
  3. (diff | hist) 16:41 Injection site rotation 3,555 +586 NauseaNoor (talk | contribs) state the assumption that the whole vial is reconstituted at once [rollback]
  4. (diff | hist) m 15:33 Lot traceability 4,002 +220 OpenLabelOtto (talk | contribs) add the turnaround time the service publishes [rollback]
  5. (diff | hist) 15:01 Hypoglycaemia 3,477 ±0 SarcopeniaSefa (talk | contribs) state whether the figure is from a trial or from post-marketing reporting [rollback]
  6. (diff | hist) 14:48 Talk:Bachem Holding (Suzhou) 1,244 +207 BalanceBirdie (talk | contribs) /* The name coincidence: how much should the article say? */ reply
  7. (diff | hist) 14:12 Research use only 6,662 +21 DMF_Dermot (talk | contribs) split overlong sentence [rollback]
  8. (diff | hist) 07:04 WuXi TIDES 8,541 ±0 VerifyVesna (talk | contribs) clarify that no manufacturing or marketing authorisation is claimed or established [rollback]
  9. (diff | hist) 04:52 Body composition assessment 3,353 +124 MetricMabel (talk | contribs) state the assay the reference interval was established on [rollback]
  10. (diff | hist) 02:44 Chain of custody 3,802 ±0 MarginNoteMars (talk | contribs) correct the description of how lot identifiers are assigned [rollback]
  11. (diff | hist) 00:53 FLOW trial 3,097 +496 PioneerPerdita (talk | contribs) state that the trial has reported but is not yet peer-reviewed [rollback]

19 January 2025

  1. (diff | hist) 17:51 Area percent purity 5,999 +685 PBM_Perrin (talk | contribs) add the detection wavelength [rollback]
  2. (diff | hist) 16:40 Hunan Aslsen Technology 6,286 +280 CouplingCillian (talk | contribs) add the see-also to the certificate-of-analysis article [rollback]
  3. (diff | hist) m b 15:46 Insulin secretion 4,555 ±0 ArchiveBot (talk | contribs) bot: update parent category chain [rollback]
  4. (diff | hist) m 13:31 Customs seizure 2,395 +31 Compounding_Cate (talk | contribs) add the effective date to the regulatory table [rollback]
  5. (diff | hist) 11:19 Number needed to treat 3,241 +34 DataTableDunja (talk | contribs) rm the cross-trial comparison; the populations are not comparable [rollback]
  6. (diff | hist) m 07:12 High-performance liquid chromatography 5,364 +646 DulaglutideDug (talk | contribs) correct the flow rate — the source gives it in mL/min [rollback]
  7. (diff | hist) m b 02:45 Underfilling 2,488 +105 CategoryBot (talk | contribs) bot: normalise citation format [rollback]

18 January 2025

  1. (diff | hist) 22:49 Fmoc chemistry 3,718 ±0 NPOV_Nadia (talk | contribs) rm the blanket claim that excursions are harmless [rollback]
  2. (diff | hist) 22:05 Survodutide 3,973 +648 Chromatokid (talk | contribs) the half-life in the lead was the terminal figure; label it as such [rollback]
  3. (diff | hist) m 17:29 MOTS-c 2,663 +54 BPC_Bramwell (talk | contribs) fix a dangling clause [rollback]
  4. (diff | hist) 13:05 Peptide aggregation 3,115 ±0 Chromatokid (talk | contribs) state that ultraviolet response is not uniform across impurities [rollback]
  5. (diff | hist) 12:49 Qingdao Sigma Chemical 7,478 +144 GradientGus (talk | contribs) attribute the documentation description to the purchaser reports it comes from [rollback]
  6. (diff | hist) 11:35 Talk:Bachem Holding (Suzhou) 1,033 +288 CoI_Corin (talk | contribs) /* The name coincidence: how much should the article say? */ reply
  7. (diff | hist) 10:21 Nantong Guangyuan Chemical 8,032 +986 Chromatokid (talk | contribs) correct the regional-warehouse list — six sites, not five [rollback]
  8. (diff | hist) 09:19 Amylin receptor agonist 3,532 +27 LedeLeander (talk | contribs) clarify that the peptide backbone is acylated rather than PEGylated [rollback]
  9. (diff | hist) m 07:11 Guangzhou JEEP Biotechnology 8,321 +522 PurityClaimPia (talk | contribs) rm the price; supplier articles carry no price per PP:VN [rollback]
  10. (diff | hist) 05:43 Sangon Biotech 4,803 +912 TallySheetTad (talk | contribs) split §Operations from §Product range [rollback]
  11. (diff | hist) 04:04 Cost per milligram 1,884 +375 SurmountSurma (talk | contribs) expand §Other axes that a price hides [rollback]
  12. (diff | hist) 01:08 Trifluoroacetate counterion 3,356 +617 AnalyticalAnnie (talk | contribs) rm the claim that the method is stability-indicating without a forced-degradation study [rollback]
  13. (diff | hist) 00:11 Adverse effects of GLP-1 receptor agonists 4,482 ±0 PancreasPru (talk | contribs) expand §Less common but significant [rollback]

17 January 2025

  1. (diff | hist) m 20:12 Good manufacturing practice 3,330 +792 ShortageShona (talk | contribs) rm the claim that the position has changed; no source supports it [rollback]
  2. (diff | hist) 17:41 C-peptide 3,250 +677 DrTitration (talk | contribs) clarify that the marker is method-dependent and not comparable across platforms [rollback]
  3. (diff | hist) 09:52 Talk:Bachem Holding (Suzhou) 822 +214 Hedgerow_Hal (talk | contribs) /* The name coincidence: how much should the article say? */ reply
  4. (diff | hist) m 08:15 Global access disparity 1,977 ±0 TelehealthTruus (talk | contribs) de-duplicate a repeated sentence [rollback]
  5. (diff | hist) 04:29 GL Biochem (Shanghai) 9,573 +110 TrialsTabitha (talk | contribs) expand §Operations and documentation practice [rollback]
  6. (diff | hist) 03:05 Bachem Holding (Suzhou) 6,624 +531 VerifyFirstVida (talk | contribs) state the city and province of the registered address [rollback]
  7. (diff | hist) 02:45 Wuhan Wansheng Biotechnology 9,206 +1,308 VerifyVesna (talk | contribs) rm a duplicated category [rollback]
  8. (diff | hist) 00:57 Amylin 3,933 +107 FmocFrancis (talk | contribs) add category for the drug class [rollback]
  9. (diff | hist) m 00:08 Shanghai Wibson Biotechnology 1,755 ±0 PurityClaimPia (talk | contribs) consistent en dashes in ranges [rollback]

16 January 2025

  1. (diff | hist) m 20:59 Beta cell function 4,328 +92 LabRangeLindy (talk | contribs) expand §What is being measured [rollback]
  2. (diff | hist) m 17:13 Weight regain after discontinuation 3,570 ±0 MTC_Marisol (talk | contribs) add the placebo rate next to the treatment rate [rollback]
  3. (diff | hist) 15:00 Insulin syringe 3,777 ±0 UnitAuditUwe (talk | contribs) rm a duplicated category [rollback]
  4. (diff | hist) 13:07 Talk:Bachem Holding (Suzhou) 611 +299 NPOV_Nadia (talk | contribs) /* The name coincidence: how much should the article say? */ reply
  5. (diff | hist) 11:09 Missed dose 3,387 +32 RotationRosalind (talk | contribs) state that reconstituted material should not be frozen, with the source [rollback]
  6. (diff | hist) 10:29 Talk:Bachem Holding (Suzhou) 400 +484 RfC_Rasmus (talk | contribs) /* The name coincidence: how much should the article say? */ new section
  7. (diff | hist) 08:47 Talk:Certificate of analysis 959 +178 ChainCustodyChad (talk | contribs) /* The seven-field table */ reply
  8. (diff | hist) 03:35 PeptideMeter 3,734 +309 GroupBuyGalen (talk | contribs) state what the certificate actually carries, field by field [rollback]
  9. (diff | hist) 01:01 Counterfeit peptide 2,733 +411 BiliaryBea (talk | contribs) add the note that self-submitted reports are a self-selected sample [rollback]

15 January 2025

  1. (diff | hist) m b 23:29 Peptide synthesis 4,113 +332 ArchiveBot (talk | contribs) bot: sort category members [rollback]
  2. (diff | hist) 21:47 Shanghai Sigma-Audley New Material Technology 6,196 +1,157 TallySheetTad (talk | contribs) rm the comparison with another supplier; there is no common basis for it [rollback]
  3. (diff | hist) 21:42 Grey market 2,576 +445 RfC_Rasmus (talk | contribs) add the shelf temperature and the primary drying step to the cycle description [rollback]
  4. (diff | hist) 16:24 Mass spectrometry 4,327 ±0 ArcuateArt (talk | contribs) correct the resolution formula — the denominator is the sum of the widths [rollback]
  5. (diff | hist) m b 15:37 ISO 9001 3,129 +127 ArchiveBot (talk | contribs) bot: flag bare reference [rollback]
  6. (diff | hist) 14:02 Talk:Certificate of analysis 748 +286 StyleSheetSybil (talk | contribs) /* The seven-field table */ reply
  7. (diff | hist) 11:57 Loss on drying 3,338 +124 Chromatokid (talk | contribs) add the system-suitability criteria the method actually specifies [rollback]
  8. (diff | hist) 11:39 Baseline laboratory panel 2,337 ±0 DrTitration (talk | contribs) clarify that the reference interval is not a treatment target [rollback]
  9. (diff | hist) 09:33 Talk:Certificate of analysis 537 +153 DefinedTermDov (talk | contribs) /* The seven-field table */ new section
  10. (diff | hist) 02:03 Prior authorisation 2,004 +212 OffLabelOdile (talk | contribs) expand §Variation [rollback]
  11. (diff | hist) 00:21 Sterility testing 3,085 +471 ArchiveAudit (talk | contribs) add category for method validation [rollback]

14 January 2025

  1. (diff | hist) m 23:44 Fasting insulin 2,290 +36 API_Aurora (talk | contribs) clarify that the reference interval is not a treatment target [rollback]
  2. (diff | hist) 22:40 Karl Fischer titration 6,021 ±0 AAA_Analyst (talk | contribs) sentence case in headings per PP:MOS [rollback]
  3. (diff | hist) 16:17 Placebo-adjusted effect 2,853 ±0 SurmountSurma (talk | contribs) add the number randomised and the number completing [rollback]
  4. (diff | hist) m 15:35 Patent expiry and biosimilars 2,578 +736 TrialsTabitha (talk | contribs) add the citation for the regulatory action [rollback]
  5. (diff | hist) N 14:30 Shanghai Wibson Biotechnology 1,755 +1,755 TallySheetTad (talk | contribs) start organisation article — registry facts and product scope only
  6. (diff | hist) m 08:18 Cold-chain freight 3,085 +574 CostPerMgCory (talk | contribs) state that overlay gas is used and name it [rollback]
  7. (diff | hist) m b 04:45 Receptor bias 3,152 +38 CategoryBot (talk | contribs) bot: expand PMID to full citation [rollback]
  8. (diff | hist) 02:33 Growth hormone secretagogue 2,721 ±0 SemaxSevi (talk | contribs) the lead said "widely used"; replaced with what the sources actually support [rollback]

13 January 2025

  1. (diff | hist) 23:19 Lyophilisation 15,434 +1,940 OpenLabelOtto (talk | contribs) sentence case in headings per PP:MOS [rollback]
  2. (diff | hist) 22:39 Contract development and manufacturing organisation 2,875 +29 TitrationTheo (talk | contribs) split §Cold chain from §Storage after receipt [rollback]
  3. (diff | hist) m 18:33 Janoshik Analytical 4,126 +388 AnalyticalAnnie (talk | contribs) clarify that a certificate is a claim by its issuer [rollback]
  4. (diff | hist) m 16:03 Exenatide 3,419 +30 INN_Ingrid (talk | contribs) expand §The extended-release formulation [rollback]
  5. (diff | hist) 14:54 Medutest 3,513 +22 SortKeySascha (talk | contribs) add the citation for the blind-sampling discussion [rollback]
  6. (diff | hist) 13:03 Dipeptidyl peptidase-4 5,763 +856 HalfLifeHavel (talk | contribs) the numbers in the lead disagreed with the body; body was right [rollback]